NEW YORK (GenomeWeb News) – Beckman Coulter has inked a deal to be exclusive distributor outside of North America for IntelliCyt's HyperCyt system, an automated platform for multiplex cell- and bead-based screening.

Beckman also will hold co-exclusive distribution rights to the system in North America for use on its own CyAn flow cytometer. Beckman said that the combination will "create the fastest available flow cytometric cell analysis system."

Albuquerque, NM-based IntelliCyt will continue to provide direct sales and support of its HyperCyt system in North America.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."